Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection.
about
Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine developmentSSP3 is a novel Plasmodium yoelii sporozoite surface protein with a role in gliding motility.HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNAImmunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malariaRecombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbsEnvelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16.A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein.HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.Plasmodium falciparum adhesion domains linked to severe malaria differ in blockade of endothelial protein C receptor.Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesHuman Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic MicePurification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity.A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140.Soluble HIV-1 envelope immunogens derived from an elite neutralizer elicit cross-reactive V1V2 antibodies and low potency neutralizing antibodiesImprovement of antibody responses by HIV envelope DNA and protein co-immunization.Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop.Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.Poly(ethyleneimine)-mediated large-scale transient gene expression: influence of molecular weight, polydispersity and N-propionyl groups.
P2860
Q21558777-D8AD687A-7FF4-4503-853E-A36991443B53Q27973415-228EE7BA-28DD-400E-8350-76A705F1FBFCQ31021712-AC5F1656-3D27-42A0-92D7-357B100368E7Q34440997-356BCAAB-0360-4BC8-B84F-FE3A139C9A09Q34539819-1B3827DE-C82F-4F94-A488-9230C8CE6B23Q34594513-80601B69-4522-4067-891D-D00CF74CB0A8Q34915786-B714B198-795E-4D80-9EF8-6BD970D07830Q35077716-961145D2-1106-476C-90DA-B6401E7E434DQ35110976-A8C255F5-1F79-4C61-83F3-7C1715C99C2AQ35566508-1E752CB5-CE43-45CC-B375-1FCA975B5F11Q35666057-95E7D59E-2320-422A-B7BD-39EE5C790FE6Q36076117-41CD4E5A-EA04-4034-8788-F4B4D9488451Q36097352-8CB33EDD-D7A9-4305-9829-1AC150210E55Q36322445-E0A9FD79-8B96-4C37-9A32-FC9C9A1174B7Q36702114-82281816-7747-488B-B0AD-CAC77DE80BF9Q36750045-AF85DD66-7971-47EA-92AB-5E6EA5141102Q36757139-5DDDA59E-CDD9-41DD-8B81-C60048921C48Q37032195-DBC3A409-9E26-40EF-9B14-D9EF59A6E9D1Q37252789-7CEF9937-AA21-4843-89DD-02624564B03AQ37510603-3B70F836-1D3B-4257-987D-834F91ECD6FAQ37588371-DDBEE563-83AA-4C98-BE20-B246906F241BQ37644030-4773847F-452F-400E-B0A6-ABA060F9ADDCQ38342167-77D97A32-CF3B-4CAF-9CFD-9B70C6BB81F5Q40385272-259A77A0-0B69-49AE-852A-C5B81E370481Q47321948-4A8EFCB8-B894-42AE-9FC2-4357EC9DE332
P2860
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Improving the expression of re ...... stable transient transfection.
@en
Improving the expression of re ...... stable transient transfection.
@nl
type
label
Improving the expression of re ...... stable transient transfection.
@en
Improving the expression of re ...... stable transient transfection.
@nl
prefLabel
Improving the expression of re ...... stable transient transfection.
@en
Improving the expression of re ...... stable transient transfection.
@nl
P2093
P1433
P1476
Improving the expression of re ...... stable transient transfection.
@en
P2093
Christine Mineart
George Sellhorn
Leonidas Stamatatos
Zachary Caldwell
P304
P356
10.1016/J.VACCINE.2009.10.028
P407
P577
2009-10-24T00:00:00Z